De Lemos-Bonotto M et al. |
A systematic review and meta-analysis of second-line immunosuppressants for autoimmune hepatitis treatment. |
2018 |
Eur J Gastroenterol Hepatol |
pmid:29227329
|
Watanabe N et al. |
The possible clinical impact of risperidone on P-glycoprotein-mediated transport of tacrolimus: A case report and in vitro study. |
2018 |
Biopharm Drug Dispos |
pmid:29055041
|
Almeida-Paulo GN et al. |
Weight of ABCB1 and POR genes on oral tacrolimus exposure in CYP3A5 nonexpressor pediatric patients with stable kidney transplant. |
2018 |
Pharmacogenomics J. |
pmid:28094348
|
Asano T et al. |
The utility of FDG-PET/CT imaging in the evaluation of multicentric reticulohistiocytosis: A case report. |
2018 |
Medicine (Baltimore) |
pmid:30113451
|
Belaiche S et al. |
Factors associated with the variability of calcineurin inhibitor blood levels in kidney recipients grafted for more than 1Â year. |
2018 |
Fundam Clin Pharmacol |
pmid:29069531
|
Wang DD et al. |
Population pharmacokinetics of tacrolimus in paediatric systemic lupus erythematosus based on real-world study. |
2018 |
J Clin Pharm Ther |
pmid:29766530
|
Krzyżowska K et al. |
Which Kidney Transplant Recipients Can Benefit from the Initial Tacrolimus Dose Reduction? |
2018 |
Biomed Res Int |
pmid:29651435
|
Takeuchi K et al. |
Comparison of Safety and Efficacy of Tacrolimus versus Infliximab for Active Ulcerative Colitis. |
2018 |
Dig Dis |
pmid:29050007
|
Mashiah J et al. |
Topical pimecrolimus for paediatric cutaneous mastocytosis. |
2018 |
Clin. Exp. Dermatol. |
pmid:29460435
|
Dheer D et al. |
Tacrolimus: An updated review on delivering strategies for multifarious diseases. |
2018 |
Eur J Pharm Sci |
pmid:29277665
|